Cohen Jonathan, Mounsambote Leonisse, Prier Perrine, Mathieu d'ARGENT Emmanuelle, Selleret Lise, Chabbert-Buffet Nathalie, Delarouziere Vanina, Levy Rachel, Darai Emile, Antoine Jean-Marie
Department of Gynecology and Obstetrics, Endometriosis Expert Center, Tenon Hospital, Pierre et Marie Curie University, Paris, France -
Université Pierre et Marie Curie, Paris, France -
Minerva Ginecol. 2017 Aug;69(4):315-321. doi: 10.23736/S0026-4784.16.04003-X. Epub 2016 Dec 21.
There is no consensual definition of diminished ovarian reserve and the best therapeutic strategy has not yet been demonstrated.
We performed a retrospective study to evaluate outcomes following a first in-vitro fertilization/intra-cytoplasmic sperm injection (IVF/ICSI) cycle in young women with diminished ovarian reserve. Women with tubal factor, endometriosis or previous stimulation cycle were excluded. We defined diminished ovarian reserve as women ≤38 years with an AMH ≤1.1 ng/mL or antral follicular count ≤7.
Among 59 IVF/ICSI cycles (40% IVF/60% ICSI), the pregnancy rate was 17% (10/59) and live birth rate 8.5% (5/59). Miscarriage rate was 50%. Baseline characteristics and IVF outcomes of the pregnant and not pregnant women were compared. No differences in age, antral follicular count, AMH, protocol used or number of harvested oocytes were found between the groups. A higher gonadotropin starting dose in the pregnancy group (397.5±87 IU vs. 314.8±103 IU; P=0.02) and a trend to a higher total dose received (4720±1349 IU vs. 3871±1367 IU; P=0.07) were noted.
The present study confirms that women with diminished ovarian reserve have low live birth rates after a first IVF-ICSI cycle and that a higher gonadotropin starting dose might be associated with better outcomes.
目前尚无关于卵巢储备功能减退的共识性定义,最佳治疗策略也尚未得到证实。
我们进行了一项回顾性研究,以评估卵巢储备功能减退的年轻女性首次体外受精/卵胞浆内单精子注射(IVF/ICSI)周期后的结局。排除输卵管因素、子宫内膜异位症或既往刺激周期的女性。我们将卵巢储备功能减退定义为年龄≤38岁、抗苗勒管激素(AMH)≤1.1 ng/mL或窦卵泡计数≤7的女性。
在59个IVF/ICSI周期中(40%为IVF/60%为ICSI),妊娠率为17%(10/59),活产率为8.5%(5/59)。流产率为50%。比较了妊娠和未妊娠女性的基线特征和IVF结局。两组在年龄、窦卵泡计数、AMH、所用方案或采集的卵母细胞数量方面均未发现差异。妊娠组的促性腺激素起始剂量较高(397.5±87 IU对314.8±103 IU;P=0.02),且总剂量有升高趋势(4720±1349 IU对3871±1367 IU;P=0.07)。
本研究证实,卵巢储备功能减退的女性在首次IVF-ICSI周期后的活产率较低,且较高的促性腺激素起始剂量可能与更好的结局相关。